wexi.
GLP-1 lineup How it works Our clinicians Compare FAQ
Sign in Start a free consultation
Home/Accessibility
Accessibility

Accessibility statement.

Last updated June 10, 2026. Wexi is working to make its website and account experience usable by as many people as possible.

Our approach

We aim to support clear language, keyboard navigation, readable contrast, responsive layouts, visible focus states, semantic HTML, and assistive-technology compatibility.

Known limitations

Some older static pages and third-party embedded services may not yet meet every accessibility expectation. We are improving these areas as the product changes.

Help and feedback

If you encounter an accessibility barrier, contact support@wexi.com with the page URL, device/browser, assistive technology if relevant, and what you were trying to do. We will do our best to provide the information or workflow another way while we investigate.

Clinical urgency

Do not use accessibility feedback channels for urgent clinical problems. Use your secure account thread for clinical care, or seek urgent local care in an emergency.

wexi

Clinician-led GLP-1 weight care, with prescriptions dispensed by licensed Canadian pharmacy partners.

Contact WexiToll-free (877) 708-9394Local (431) 816-9394Email support@wexi.com

Weight loss
  • Wegovy®
  • Ozempic®
  • Mounjaro®
  • Zepbound®
  • Rybelsus®
  • Saxenda®
  • Generic semaglutide
Wexi
  • About
  • Our clinicians
  • How it works
  • FAQ
  • Guides
  • Contact
Policies
  • Privacy
  • Terms
  • Accessibility
  • Shipping & returns

© 2026 Wexi Health Inc. · Prescription medications are dispensed by licensed Canadian pharmacy partners. Wegovy®, Ozempic®, Rybelsus® and Saxenda® are registered trademarks of Novo Nordisk. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Wexi is not affiliated with these manufacturers.

Verify Approval for www.wexi.com